49
3
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36466 |
Chlorin E6
Ce6,Chlorin e6,CE6 |
Parasite | Microbiology/Virology |
Chlorin E6 (CE6) 是一种第二代光敏剂,在与辐照结合使用时具有抗肿瘤活性。在植入性纤维肉瘤的小鼠模型中,Chlorin E6(2.5-10 毫克/千克,静脉注射,50-200 焦耳/平方厘米的辐照)在不同程度的辐照后会导致肿瘤完全消失。在一项针对支气管源性早期浅表鳞状细胞癌患者的 I 期临床研究中,对包括 Chlorin E6 在内的制剂进行了测试,结果良好(40 毫克/平方米,静脉注射,100 焦耳/平方厘米的激光辐照)。在一项针对早期肺癌患者的二期临床试验中,同样的给药模式使 82.9% 的患者获得了完全应答。Chlorin E6 已被研究为一种纳米技术给药工具。 | |||
T40435 |
Chlorin e6 trimethyl ester
二氢卟吩 e6 三甲酯 |
||
Chlorin e6 trimethyl ester, a derivative of methyl pheophorbide-a, is an effective photosensitizer for photodynamic therapy (PDT). | |||
T1254 |
Chlorophyllin sodium copper salt
Chlorophyllin copper sodium complex,Chlorophyllin,叶绿素铜钠盐,Chlorophyllin coppered trisodium salt,Sodium-copper chlorin e6 |
Others | Others |
Chlorophyllin sodium copper salt (Chlorophyllin coppered trisodium salt) 是一种由 Chlorophyll 衍生的铜钠盐的半合成混合物,常用作食品添加剂。 | |||
T16978 |
Talaporfin sodium
ME2906,他拉泊芬钠,NPe6,Mono-L-aspartyl chlorin e6 |
Others | Others |
Talaporfin is a photosensitizer used in photodynamic therapy. | |||
T60014 |
SHEN26
|
Antiviral | Immunology/Inflammation |
SHEN26 具有抗病毒活性,可用于治疗病毒感染的研究。 | |||
T0711 |
Niclosamide
BAY2353,Niclocide,氯硝柳胺 |
Antibiotic; STAT; Parasite | JAK/STAT signaling; Microbiology/Virology; Stem Cells |
Niclosamide (Niclocide) 是一种口服生物可利用的氯化水杨酰苯胺。它通过抑制 DNA 复制,具有驱虫和潜在的抗肿瘤活性。 | |||
T1406 |
Amantadine hydrochloride
盐酸金刚烷胺,1-adamantanamine HCl,1-Adamantanamine hydrochloride,Symmetrel,CI-719,Amantadine HCl,1-Adamantylamine hydrochloride |
Dopamine Receptor; Influenza Virus | GPCR/G Protein; Microbiology/Virology; Neuroscience |
Amantadine hydrochloride (CI-719) 是一种抗病毒药物,用于预防或对症治疗甲型流感和帕金森病。它阻断质子流通过 M2 离子通道,从而阻止病毒 RNA 释放到感染细胞的细胞质中。 | |||
T4068 |
E6446 dihydrochloride
|
TLR | Immunology/Inflammation |
E6446 dihydrochloride 是一种新型合成拮抗剂,用于核酸感应 TLR;有效抑制对 HEK:TLR9 细胞的 DNA 刺激,IC50 为 10 nM。 | |||
T4206 |
E6446
|
TLR | Immunology/Inflammation |
E6446 抑制 Toll 样受体 (TLR)7 和 9 信号传导。 E6446 在多种人和小鼠细胞类型中起作用,并在体外抑制 DNA-TLR9 相互作用。当给予小鼠时,该化合物抑制对刺激 TLR9 的含有胞苷-磷酸-胍 (CpG) 的 DNA 的挑战剂量的反应。 | |||
T31592 |
E6801
E 6801,E-6801 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
E6801是一种新型选择性5-HT6受体激动剂,具有广泛的生物活性。E6801可用于研究痴呆、帕金森病、抑郁症、肥胖症癫痫,焦虑等多种疾病。 | |||
TP2103L |
[D-p-Cl-Phe6,Leu17]-VIP acetate
|
Others | Others |
[D-p-Cl-Phe6,Leu17]-VIP acetate 是一种竞争性和选择性的血管活性肠肽 (VIP) 受体拮抗剂 (IC50 = 125.8 nM)。 | |||
T11141 |
E64FC26
|
Others | Others |
E64FC26 是一种有效的蛋白质二硫键异构酶 (PDI) 家族泛抑制剂,具有抗肿瘤活性,抑制 PDIA1、PDIA3、PDIA4、TXNDC5 和 PDIA6,可用于研究多发性骨髓瘤和胰腺癌。 | |||
T78003 |
[D-p-Cl-Phe6,Leu17]-VIP TFA
|
||
[D-p-Cl-Phe6,Leu17]-VIP TFA,为竞争性及选择性血管活性肠肽(VIP)受体拮抗剂,其IC50为125.8 nM。该化合物针对胰高血糖素、促胰液素和GRF受体均不表现活性。 | |||
T11442 |
GNE684
|
TNF | Apoptosis |
GNE684 是一种有效的受体相互作用蛋白 1(RIP1)抑制剂,对人类、小鼠与大鼠 RIP1 的平均Kiapp 值分别为 21 nM、189 nM 和 691 nM。 | |||
T62678 | YE6144 | ||
YE6144 是一种典型的干扰素调节因子 5 (IRF5) 抑制剂。YE6144 能够抑制 IRF5 磷酸化,进而选择性抑制 IRF5 活性。 | |||
T38774 |
E67-2
E67-2 |
||
E67-2, a derivative of E67, is a low-toxicity, selective inhibitor of the KIAA1718 Jumonji domain. It has an IC 50 value of 3.4 μM. E67-2 specifically inhibits the Jumonji demethylase for histone H3 lysine 9 (H3K9) and histone H3 lysine 4 (H3K4) demethylase. | |||
T36651 |
Anti-MERS-2E6 mAb
Anti-MERS-2E6 mAb |
||
Anti-MERS-2E6 mAb (MERS-2E6), a human IgG1 neutralizing antibody, is expressed in CHO cells. It effectively competes with the virus Spike protein for binding to the CD26 receptor, consequently inhibiting viral invasion into host cells. | |||
TF0030 |
Hexaethylene Glycol Monodecyl Ether (C10E6)
|
||
Hexaethylene Glycol Monodecyl Ether (C10E6) 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0030,CAS号为 5168-89-8。 | |||
T81254 |
RPE65-IN-1
|
||
RPE65-IN-1(Compound 16e)为高效RPE65抑制剂,适用于视网膜疾病相关研究。 | |||
TF0029 | Hexaethylene Glycol Monooctyl Ether (C8E6) | ||
Hexaethylene Glycol Monooctyl Ether (C8E6) 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0029,CAS号为 4440-54-4。 | |||
T76601 |
(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14)
|
||
'(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin(6-14)是一种蛙皮素(bombesin)拮抗剂,主要应用于癌症研究领域。' | |||
T83945 |
XIE62-1004
|
||
XIE62-1004 是一种促进p62与LC3相互作用的诱导剂。通过与p62的ZZ域结合,导致p62自我聚集并与自噬体膜上的LC3相互作用;促进货物蛋白被送往自噬体以便降解。在体外及体内以浓度依赖和时间依赖的方式活性,并特异性针对野生型p62。在体外诱导突变型huntingtin的降解。也可以用于AUTAC蛋白质降解系统,通过p62自我聚集及与LC3的相互作用来诱导自噬。 | |||
T39812 |
(E/Z)-E64FC26
(E/Z)-E64FC26 |
||
(E/Z)-E64FC26 is a mixture complex comprising E-E64FC26 and Z-E64FC26. E-E64FC26 is a highly potent pan-inhibitor of the protein disulfide isomerase (PDI) family, with IC50 values of 1.9, 20.9, 25.9, 16.3, and 25.4 μM against PDIA1, PDIA3, PDIA4, TXNDC5, and PDIA6, respectively. Furthermore, E64FC26 demonstrates anti-myeloma activity. | |||
T61755 |
E6201
|
||
E6201 (ER-806201) is a potent dual kinase inhibitor targeting MEK1 and FLT3, inhibiting their activities in an ATP-competitive manner. It effectively suppresses MEK1-induced ERK2 phosphorylation (IC50 = 5.2 nM), MKK4-induced JNK phosphorylation (IC50 = 91 nM), and MKK6-induced p38 MAPK phosphorylation (IC50 = 19 nM). E6201 exhibits anti-tumor and anti-psoriasis effects [1] [2]. | |||
TF0071 |
Hexaethylene Glycol Monododecyl Ether (C12E6)
|
||
Hexaethylene Glycol Monododecyl Ether (C12E6) 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0071,CAS号为 3055-96-7。 | |||
T10555 |
BJE6-106
B106 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
BJE6-106 (B106) is a potent, selective PKCδ inhibitor (IC50: 0.05 μM) and targets selectivity over classical PKCα (IC50: 50 μM). BJE6-106 induces caspase-dependent apoptosis with tumor-specific effect. | |||
T11140 |
E6130
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
E6130 may be effective in the treatment of inflammatory bowel disease and is a highly selective CX3CR1 regulator for oral administration. | |||
T70900 |
VT-ME6
|
||
VT-ME6 is a potent and selective sphingosine kinase 2 inhibitor. VT-ME6, contained a quaternary ammonium group as a warhead and established that a positively charged moiety is necessary for engaging key amino acid residues in the enzyme binding pocket.13,14 This compound is moderately potent (Ki = 8 lM) and displays three-fold selectivity for SphK2 over SphK1. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK... | |||
TP2103 |
[D-p-Cl-Phe6,Leu17]-VIP
|
||
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors. | |||
T33267 |
Me6TREN 4HCl
Me6TREN Tetrahydrochloride,Me6-TREN Tetrahydrochloride,Me6 4HCl,Me 6 4HCl,Me-6 4HCl |
||
Me6TREN 4HCl is a potent and efficacious mobilizing agent of hematopoietic stem and progenitor cells (HSPCs) that can act by activating MMP-9 expression and disrupting the SDF-1α/CXCR4 axis, exhibiting more significant mobilizing effects than G-CSF or AMD | |||
T17228 |
Sabizabulin
ABI-231,VERU-111 |
Microtubule Associated | Cytoskeletal Signaling |
Sabizabulin (ABI-231) 是一种有效且具有口服生物利用度的 α 和 β 微管蛋白抑制剂,可对抗黑色素瘤和前列腺癌细胞系。 Sabizabulin 通过靶向 HPV E6 和 E7 抑制宫颈癌细胞的肿瘤生长和转移表型。 Sabizabulin 显示出抗增殖活性,可用于前列腺癌研究。 | |||
T37173 |
MPro Inhibitor 11a
|
||
MProinhibitor 11a is an inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro; IC50= 0.053 μM in a TR-FRET assay).1It reduces viral yield in the culture supernatant of SARS-CoV-2-infected Vero E6 cells (EC50= 0.53 μM). MProinhibitor 11a also reduces viral RNA copy numbers in the same model when used at concentrations ranging from 1.85 to 50 μM. 1.Dai, W., Zhang, B., Jiang, X.-M., et al.Structure-based design of antiviral drug candidates targeting the SARS-... | |||
T1307 |
Carmofur
HCFU,卡莫氟 |
Nucleoside Antimetabolite/Analog; Virus Protease; SARS-CoV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Carmofur (HCFU) 是 5-氟尿嘧啶的衍生物,是一种抗肿瘤药物。它是一种酸性神经酰胺酶抑制剂,用于治疗乳腺癌和结直肠癌。它抑制 SARS-CoV-2主要蛋白酶,还抑制 Vero E6 细胞 SARS-CoV-2,EC50为 24.3 μM。 | |||
T15172 |
DSHS00884
SSYA10-001 |
Others | Others |
DSHS00884 is a potent inhibitor of human papillomavirus E6 (IC50: 10 μM). | |||
T71941 |
Lig3
|
||
Lig3 is an inhibitor against high-risk strains of human papillomavirus (HPV) E6 oncoprotein. | |||
T28534 |
RH02007
CCG 40788,RH-02007,CCG40788,CCG-40788,RH 02007 |
||
RH02007 is an inhibitor of the human papillomavirus (HPV) E6 oncoprotein. | |||
T40207 | SARS-CoV-2-IN-7 | ||
SARS-CoV-2-IN-7 demonstrates potent inhibition of viral replication in SARS-CoV-2-infected Vero E6 cells with an IC50 value of 844 nM. | |||
T72519 |
Niclosamide sodium
BAY2353 sodium |
||
Niclosamide (BAY2353) sodium 为用于研究寄生虫感染的口服抗蠕虫化合物,同时是STAT3抑制剂,在HeLa细胞中IC50为0.25μM。此化合物显示抗癌生物活性,并可抑制Vero E6细胞DNA复制。 | |||
T79328 |
SARS-CoV-2-IN-54
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-54(Compound 2)为针对SARS-CoV-2的抑制剂,展现出抗病毒活性。它能在Vero E6细胞中抑制SARS-CoV-2,其IC50值为21.4 μM。 | |||
T81209 |
SARS-CoV-2-IN-62
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-62 (Compound R3b) 为SARS-CoV-2复制抑制剂,细胞毒性较低。在Vero E6细胞和Calu-3细胞中,其抑制病毒复制的EC50值分别为2.97 μM与3.82 μM。 | |||
T79661 |
SARS-CoV-2 3CLpro-IN-18
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-18(Compound 3C)为一种共价SARS-CoV-2 3CLpro抑制剂,具有0.478 μM的IC50值。在Vero E6细胞中对SARS-CoV-2展现出2.499 μM的EC50抑制活性,并显示出较低的细胞毒性(CC50> 200 μM)。 | |||
T79329 |
SARS-CoV-2-IN-56
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-56(Compound 63)是具有抗病毒活性的SARS-CoV-2抑制剂,能在Vero E6 细胞中抑制SARS-CoV-2,其IC50为0.7 μM。 | |||
T79455 | SARS-CoV-2 Mpro-IN-9 | SARS-CoV | Microbiology/Virology |
SARS-CoV-2 Mpro-IN-9 (compound c7) 是非肽类、非共价型SARS-CoV-2 Mpro抑制剂,IC50值为0.085 μM,展现出改进的物化特性和药物代谢及药动学 (DMPK) 性质。在Vero E6 细胞中,对SARS-CoV-2感染显示抑制效果,EC50为1.10 μM,同时具备低细胞毒性(CC50>50 μM)。 | |||
T79462 |
SARS-CoV-2 3CLpro-IN-14
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-14(compound 11j)为口服活性SARS-CoV-2 3CLpro抑制剂,于Vero E6细胞中对SARS-CoV-2展现出高效抗活性(EC50=0.18 μM),且具备低细胞毒性(CC50>50 μM)。 | |||
T36435 |
SP 10
|
||
Peptide originally derived from SARS-CoV Spike (S) protein; corresponds to amino acid residues 668 to 679. Highly potent inhibitor of SARS-CoV S protein and ACE2 interaction (IC50 = 1.88 nM in biochemical assay). Inhibits interaction of SARS-CoV S protein and Vero E6 cells in vitro. Please note, this peptide displays 80% sequence identity to homologous site on SARS-CoV-2 S-protein (residues 689-697). | |||
T81208 |
SARS-CoV-2-IN-63
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-63(Compound R3e)是一种针对SARS-CoV-2病毒复制的抑制剂,具备较低的细胞毒性。在Vero E6细胞和Calu-3细胞中对SARS-CoV-2的抑制作用表现出EC50值分别为1.99 μM与1.92 μM。 | |||
T80686 |
γ-AA peptide P6
|
||
γ-AA peptide P6 作为E6相关蛋白(E6AP)的有效激活剂, 在体外重组反应中能够促进E6AP的自我泛素化以及催化底物的泛素化作用。此外,γ-AA peptide P6 在细胞内部能够增强E6AP底物的泛素化,并加速其通过蛋白酶体的降解过程。 | |||
T37174 |
SARS-CoV MPro-IN-1
|
||
MProinhibitor 11b is an inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro; IC50= 0.04 μM in a TR-FRET assay).1It reduces viral yield in the culture supernatant of SARS-CoV-2-infected Vero E6 cells (EC50= 0.72 μM). MProinhibitor 11b also reduces viral RNA copy numbers in the same model when used at concentrations ranging from 1.85 to 50 μM. 1.Dai, W., Zhang, B., Jiang, X.-M., et al.Structure-based design of antiviral drug candidates targeting the SARS-C... | |||
T83947 |
HDAC4 CHDI Degrader 11
|
||
HDAC4 CHDI Degrader 11是一种高效且选择性的HDAC4降解剂(PROTAC),其在Jurkat E6-1细胞和Jurkat细胞中的DC50值分别为4 nM和6 nM。该化合物由类IIa HDAC抑制剂三氟甲基噁二唑通过连接体与Von Hippel-Lindau (VHL) 蛋白的配体连接而成。在亨廷顿病小鼠细胞模型中,HDAC4 CHDI Degrader 11能强效地降解HDAC4(DC50= 1nM)。在神经母细胞瘤细胞系中,可与P-糖蛋白抑制剂Elacridar联用以实现更有效的降解。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7060 |
Amantadine
1-Aminoadamantane,1-金刚烷胺,金刚烷胺,1-Adamantanamine,1-Adamantylamine |
Others | Others |
Amantadine (1-Aminoadamantane) 是抗病毒药物,也是是 NMDA 型谷氨酸受体的弱拮抗剂,能促进高多巴胺的释放,并阻断多巴胺的再摄取。 | |||
TN2149 |
Reynosin
|
BCL; Others; TNF | Apoptosis; Others |
Reynosin has hepatoprotective, and anti-inflammatory effects, it has protective effect against dopamine-induced neuronal cell death, which may be due to the reciprocal up-regulation of E6-associated protein and down-regulation of α±-synuclein protein expr | |||
T79941 |
Antimycin A2c
|
Apoptosis | Apoptosis |
Anticanceragent 141(compound AE)是一种针对HPV感染宫颈癌具有抑制作用的抗霉素生物碱。该化合物能够抑制宫颈癌HeLa细胞的增殖并导致细胞周期在S期停滞。Anticanceragent 141破坏线粒体功能,诱导caspase依赖性细胞凋亡,并激活ROS介导的泛素依赖性蛋白酶体系统,进而引起E6/E7癌蛋白的降解。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01467 |
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His & Avi)
HPV16,E6,Human papillomavirus type 16 |
Human | HEK293 Cells |
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer. | |||
TMPK-01466 |
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Tetramer Protein, Human, MHC (His & Avi)
Human papillomavirus type 16,E6,HPV16 |
Human | HEK293 Cells |
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer. | |||
TMPH-01833 |
Human Papilloma Virus type 16 (HPV 16) Protein E6 (His)
|
HPV 16 | P. pastoris (Yeast) |
Human Papilloma Virus type 16 (HPV 16) Protein E6 (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 21.2 kDa and the accession number is P03126. | |||
TMPH-01832 |
Human Papilloma Virus type 16 (HPV 16) Protein E6 (E. coli, His)
|
HPV 16 | E. coli |
Human Papilloma Virus type 16 (HPV 16) Protein E6 (E. coli, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 23.2 kDa and the accession number is P03126. | |||
TMPH-02033 |
RPE65 Protein, Human, Recombinant (His & Myc)
|
Human | Baculovirus Insect Cells |
RPE65 Protein, Human, Recombinant (His & Myc) is expressed in Baculovirus. | |||
TMPJ-01258 |
RNASE6 Protein, Human, Recombinant (His)
RNS6,Ribonuclease K6,RNase K6,RNASE6 |
Human | HEK293 Cells |
Ribonuclease K6 (RNASE6) is a secreted protein that belongs to the pancreatic ribonuclease family. Human RNASE6 is synthesized as a 150 amino acid precursor that contains a 23 amino acid signal sequence, and a 127 amino acid mature chain. RNASE6 is expressed in many tissues, with high expression levels in the lung, with lower expression levels in the heart, placenta, kidney, pancreas, liver, brain, and skeletal muscle. It is also detected in monocytes and neutrophils. RNASE6 may have a role in h... | |||
TMPY-02842 |
UBE2L6 Protein, Human, Recombinant (His)
UBCH8,ubiquitin-conjugating enzyme E2L 6,RIG-B |
Human | E. coli |
UBCH8, also known as UBE2L6, belongs to the ubiquitin-conjugating enzyme family. The family of ubiquitin-conjugating (E2) enzymes is characterized by the presence of a highly conserved ubiquitin-conjugating (UBC) domain. These domains accommodate the ATP-activated ubiquitin (Ub) or ubiquitin-like (UBL) protein via a covalently linked thioester onto its active-site residue. E2 enzymes act via selective protein-protein interactions with the E1 and E3 enzymes and connect activation to covalent modi... |